Back
ProShares Ultra Nasdaq Biotechnology Stock Price Chart
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
41
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
$41.50
Seasonality Move:
12.2%
7 Day Trial
ALL ACCESS PASS
$
7
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
ProShares Ultra Nasdaq Biotechnology Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.45 | Sell |
| 20-day SMA: | 43.64 | Sell |
| 50-day SMA: | 47.13 | Sell |
| 200-day SMA: | 56.68 | Sell |
| 8-day EMA: | 42.79 | Buy |
| 20-day EMA: | 43.79 | Sell |
| 50-day EMA: | 46.47 | Sell |
| 200-day EMA: | 53.23 | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.08 | Sell |
| Relative Strength Index (14 RSI): | 47.02 | Sell |
| Chaikin Money Flow: | 28793 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.73 - 45.67) | Buy |
| Bollinger Bands (100): | (45.08 - 55.72) | Sell |
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ProShares Ultra Nasdaq Biotechnology Stock
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 43.10 while BIB 8-day simple moving average is 43.45, which is a Sell signal.
-
The stock price of BIB is 43.10 while ProShares Ultra Nasdaq Biotechnology 20-day SMA is 43.64, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day simple moving average is 47.13 while BIB share price is 43.10, making it a Sell technically.
-
BIB stock price is 43.10 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 56.68, creating a Sell signal.
BIB Technical Analysis vs Fundamental Analysis
Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy or a Sell?
-
ProShares Ultra Nasdaq Biotechnology stock is rated a SellThe current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $43.10. The Score for BIB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
ProShares Ultra Nasdaq Biotechnology Stock Info
Market Cap:
0
Price in USD:
43.10
Share Volume:
35.6K
ProShares Ultra Nasdaq Biotechnology 52-Week Range
52-Week High:
69.56
52-Week Low:
33.78
Sell
41
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
ProShares Ultra Nasdaq Biotechnology Share Price Forecast
-
What is the ProShares Ultra Nasdaq Biotechnology stock price today?The ProShares Ultra Nasdaq Biotechnology stock price is 43.10 USD today.
-
Will BIB stock go up or go down?ProShares Ultra Nasdaq Biotechnology> share price is forecast to RISE/FALL based on technical indicators
-
Is ProShares Ultra Nasdaq Biotechnology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProShares Ultra Nasdaq Biotechnology is overvalued.
Is ProShares Ultra Nasdaq Biotechnology Stock a Buy?
-
ProShares Ultra Nasdaq Biotechnology share price is 43.10 while BIB 8-day exponential moving average is 42.79, which is a Buy signal.
-
The stock price of BIB is 43.10 while ProShares Ultra Nasdaq Biotechnology 20-day EMA is 43.79, which makes it a Sell.
-
ProShares Ultra Nasdaq Biotechnology 50-day exponential moving average is 46.47 while BIB share price is 43.10, making it a Sell technically.
-
BIB stock price is 43.10 and ProShares Ultra Nasdaq Biotechnology 200-day simple moving average is 53.23, creating a Sell signal.
Technical Analysis of ProShares Ultra Nasdaq Biotechnology
Should I short ProShares Ultra Nasdaq Biotechnology stock?
-
BIB Moving Average Covergence Divergence (MACD) indicator is -1.08, suggesting ProShares Ultra Nasdaq Biotechnology is a Sell
-
ProShares Ultra Nasdaq Biotechnology Relative Strength Index (RSI) is 47.02, which suggest ProShares Ultra Nasdaq Biotechnology is oversold
-
The Bollinger Bands (25) for ProShares Ultra Nasdaq Biotechnology is (39.73 - 45.67), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
-
The Bollinger Bands (100) for ProShares Ultra Nasdaq Biotechnology is (45.08 - 55.72), which suggest ProShares Ultra Nasdaq Biotechnology is a Sell
* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.